Caption Management, LLC Drug Manufacturers

Caption Management, LLC

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
TEVA Teva Pharmaceutical Industries LTD	$24.7B	$3.32 Million 0.06% of portfolio	184,300	Q3 2024 Added 332.63%
PRGO Perrigo CO PLC	$3.45B	$1.73 Million 0.03% of portfolio	66,000	Q3 2024 Added 32.0%
ALKS Alkermes Plc.	$4.85B	$1.69 Million 0.03% of portfolio	60,326	Q3 2024 New
BHC Bausch Health Companies Inc.	$2.71B	$1.43 Million 0.02% of portfolio	175,181	Q3 2024 Added 7,345.01%
ELAN Elanco Animal Health Inc	$5.62B	$734,000 0.01% of portfolio	50,000	Q2 2024 Reduced 77.17%
CRON Cronos Group Inc.	$760M	$495,000 0.01% of portfolio	225,292	Q3 2024 Added 4.31%
NBIX Neurocrine Biosciences Inc	$13.1B	$333,000 0.01% of portfolio	2,900	Q3 2024 Reduced 94.03%
EMBC Embecta Corp.	$1.17B	$121,000 0.0% of portfolio	8,600	Q3 2024 New
EOLS Evolus, Inc.	$608M	$102,000 0.0% of portfolio	6,300	Q3 2024 New
LNTH Lantheus Holdings, Inc.	$6.26B	$21,000 0.0% of portfolio	200	Q3 2024 New
ASRT Assertio Holdings, Inc.	$41M	$3,000 0.0% of portfolio	2,600	Q1 2024 Reduced 94.12%

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.